Applications Open for NJEDA’s Construction Inflation Fund
TRENTON, N.J. (September 5, 2023) – The New Jersey Economic Development Authority (NJEDA) is now accepting applications for the Construction Inflation Fund, which will provide grants for development projects experiencing increased construction costs and funding gaps resulting from inflation caused by the COVID-19 pandemic. The $10 million program offers grants of up to 20 percent of total project costs.
WHAT: The Construction Inflation Fund, funded at $10 million, is a competitive grant program created to address the impacts of COVID-19. The Fund aims to mitigate the negative economic impacts of the pandemic by providing support to real estate development in the form of grants for real estate substantial rehabilitation, new construction, and development costs associated to each project.
The Fund was created through the federal American Rescue Plan’s Coronavirus State and Local Fiscal Recovery Funds. The Fiscal Year 2023 State Budget appropriated ARP funds for “Real Estate Gap Financing”, which led to the creation of the Construction Inflation Fund.
WHERE: Applications for the Construction Inflation Fund can be found here. Questions from interested parties can be submitted to realestateinfo@njeda.gov.
WHEN: Applications must be submitted by October 19, 2023 at 5:00 p.m.
To learn more about NJEDA resources for businesses, call NJEDA Customer Care at 844-965-1125 or visit https://www.njeda.gov and follow @NewJerseyEDA on Facebook, Twitter, Instagram, and LinkedIn.
###
Related Content
October 30, 2026
NJEDA CAFE Program Will Support Renovations to Lucy the Elephant
TRENTON, N.J. (October 30, 2026) – Recently, the New Jersey Economic Development Authority (NJEDA) Board approved a Cultural Arts Facilities Expansion (CAFE) Program award to support Lucy the Elephant in Margate City.
October 26, 2026
NJEDA Approves Next New Jersey Manufacturing Award to Support Amneal Pharmaceuticals’ New Jersey Expansion
TRENTON, N.J. (October 26, 2026) – The New Jersey Economic Development Authority (NJEDA) Board recently approved approximately $60 million in tax credits under the Next New Jersey Manufacturing Program to support a planned manufacturing expansion by Amneal Pharmaceuticals, a global biopharmaceutical company focused on developing, manufacturing, commercializing, and distributing affordable and innovative medicines.
October 23, 2026
NJEDA Aspire Program Advances Affordable Residential Projects in Newark
TRENTON, N.J. (October 23, 2026) – Yesterday, the New Jersey Economic Development Authority (NJEDA) Board approved three awards under the Aspire Program to support affordable residential development projects in Newark.